ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy

Yang, Jiabin; Zeng, Liangtang; Chen, Ruiwan; Zheng, Shangyou; Zhou, Yu*; Chen, Rufu*广东省人民医院; 南方医科大学; 中山大学; 1; y
Frontiers in Immunology2023-3-16DOI: 10.3389/fimmu.2023.1076587
5阅读
引用收藏
分享

摘要

BackgroundMetabolic reprogramming is a well-known hallmark of cancer. Systematical identification of clinically relevant metabolic subtypes of Hepatocellular carcinoma (HCC) is critical to understand tumor heterogeneity and develop efficient treatment strategies. MethodsWe performed an integrative analysis of genomic, transcriptomic, and clinical data from an HCC patient cohort in The Cancer Genome Atlas (TCGA). ResultsFour metabolic subtypes were defined: mHCC1, mHHC2, mHCC3, and mHCC4. These subtypes had distinct differences in mutations profiles, activities of metabolic pathways, prognostic metabolism genes, and immune features. The mHCC1 was associated with poorest outcome and was characterized by extensive metabolic alterations, abundant immune infiltration, and increased expression of immunosuppressive checkpoints. The mHHC2 displayed lowest metabolic alteration level and was associated with most significant improvement in overall survival in response to high CD8+ T cell infiltration. The mHHC3 was a "cold-tumor" with low immune infiltration and few metabolic alterations. The mHCC4 presented a medium degree of metabolic alteration and high CTNNB1 mutation rate. Based on our HCC classification and in vitro study, we identified palmitoyl-protein thioesterase 1 (PPT1) was a specific prognostic gene and therapeutic target for mHCC1. ConclusionOur study highlighted mechanistic differences among metabolic subtypes and identified potential therapeutic targets for subtype-specific treatment strategies targeting unique metabolic vulnerabilities. The immune heterogeneities across metabolic subtypes may help further clarify the association between metabolism and immune environment and guide the development of novel strategies through targeting both unique metabolic vulnerabilities and immunosuppressive triggers.

学科与关键词

关键词
hepatocellular carcinomametabolismdifferential gene expressionpersonalized treatmentmetabolic subtypePPT1
相关
加载中…
  • Tumor biology, immune infiltration and liver function define seven hepatocellular carcinoma subtypes linked to distinct drivers, survival and drug response
    Wu, Ruihong; Gao, Yue; Zhao, Xiaoxi; Guo, Shuang; Zhou, Hanxiao; Zhang, Yakun; Hou, Yaopan; Mei, Lan; Zhi, Hui; Wang, Peng; Li, Xia*; Ning, Shangwei*; Zhang, Yunpeng*Computers in Biology and Medicine, 2023, 167: 107593.被引 2
  • Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis
    Deng, Weijie; Zhu, Peng; Xu, Huixuan; Hou, Xianliang; Chen, Wenbiao*Journal of Oncology, 2022, 2022: 2014625.被引 1
  • Reprogramming of central carbon metabolism in hepatocellular carcinoma
    Xia, Haoming; Huang, Ziyue; Xu, Yi*; Yam, Judy Wai Ping*; Cui, Yunfu*Biomedicine and Pharmacotherapy, 2022, 153: 113485.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2023-03-16
卷期
第 14 卷
页码
1076587
DOI
10.3389/fimmu.2023.1076587
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072639]; Special Fund of "Dengfeng Plan" of Guangdong Provincial People's Hospital, China [KJ012019509, DFJH2020027]; Outstanding Youth Scholars Project of Guangdong Provincial People's Hospital [KJ012019096]

作者

  • Y

    Yang, Jiabin (第一作者)

    guangdong prov peoples hosp · southern med univ

  • Z

    Zeng, Liangtang

    guangdong prov peoples hosp · southern med univ

查看全部 6 位作者收起作者
  • C

    Chen, Ruiwan

    1 · sun yat sen univ

  • Z

    Zheng, Shangyou

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhou, Yu (通讯)

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Rufu (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417